U.S. Markets open in 7 hrs 47 mins

Comparing the EPS Trajectory of FOLD and PTLA in Fiscal 2019

Margaret Patrick
Comparing the EPS Trajectory of FOLD and PTLA in Fiscal 2019

Amicus or Portola: Which Is the Best Bet in May?(Continued from Prior Part)First-quarter performanceIn the first quarter, Amicus Therapeutics (FOLD) reported non-GAAP EPS of -$0.39, a YoY fall of 39.29% and lower than the consensus estimate by